Organon (OGN) Receivables - Net (2020 - 2026)
Organon (OGN) posted quarterly Receivables - Net of $1.4 billion for Q1 2026, down 5.01% year-over-year from $1.5 billion in Q1 2025, and up 3.98% on a QoQ basis from $1.3 billion in Q4 2025.
Organon (OGN) Receivables - Net (2020 - 2026) Analysis & Trends
Organon (OGN) has reported Receivables - Net for 7 consecutive years, with $1.4 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net fell 5.01% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (down 5.01% YoY), while the FY2025 annual figure was $1.3 billion, down 1.99% from the prior year.
- Receivables - Net came in at $1.4 billion for Q1 2026 at Organon, up from $1.3 billion in the prior quarter.
- The five-year high for Receivables - Net was $1.7 billion in Q4 2023, with the low at $1.3 billion in Q1 2022.
- Average Receivables - Net over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2025.
- Across the five-year window, Receivables - Net jumped 30.89% in 2022 and slipped 22.13% in 2024, its largest moves.
- Year by year, Receivables - Net stood at $1.5 billion in 2022, then gained by 18.24% to $1.7 billion in 2023, then dropped by 22.13% to $1.4 billion in 2024, then dropped by 1.99% to $1.3 billion in 2025, then climbed by 3.98% to $1.4 billion in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $1.4 billion, $1.3 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Bn |
| Mar 31, 2026 | 1.38 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.48 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Sep 30, 2024 | 1.69 Bn |
| Sep 30, 2024 | 1.69 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Dec 31, 2023 | 1.74 Bn |
| Dec 31, 2023 | 1.74 Bn |